Navigation Links
Elected Officials Voting Against Health Reform Received 65% More in Campaign Donations From Health and Insurance Interests Than Those Voting for Reform
Date:7/27/2009

the study.

"The blocs of lawmakers on both the House Energy and Commerce and Senate Finance Committees who are slowing the pace and scope of reform are also huge recipients of health and insurance money."

The report, entitled "Five Committees, Three Votes: Advancing Health Care Reform Through the Swamp of $187 Million in Interested Political Money," reviewed the lifetime campaign contributions from health and insurance interests, as coded by the Center for Responsive Politics, to members of Congress currently serving on the following committees: House Ways and Means; House Education and Labor; House Energy and Commerce; Senate Health, Education, Labor, and Pensions (HELP); and Senate Finance. Comprehensive health reform legislation has passed three of the committees - House Ways and Means; House Education and Labor; and Senate HELP.

The research found that members on three congressional committees who voted against health care reform received, on average, $353,105 more from the health and insurance industries, or 65% more, than their colleagues who voted for reform.

Other findings included:

  • The seven Blue Dog House members who are negotiating with the Energy and Commerce Chairman Henry Waxman have received significantly more money from the industries than their Democratic colleagues on the committee.
  • The 82 members of the two committees that have yet to vote on legislation -- the House Energy and Commerce Committee and the Senate Finance Committee -- took nearly $100 million from health and insurance interests over their career.

"These findings point to the need for Congress to pass the Fair Elections Now Act, which would free elected officials from the pressures of fundraising," commented Donnelly.

The full report can be found here:'/>"/>

SOURCE Public Campaign Action Fund
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
5. Montana Health Care Leader Elected Board Chair of National Association
6. Fry Construction Selected for High-Profile Medical Imaging Project
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Meth Project Advertisements Selected for National Prevention Campaign
9. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
10. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
11. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., , SOUTHBRIDGE, Mass., Dec. 3 /PRNewswire/... approval to treat its first patients, Harrington ...t seeing patients immediately," said Diane Becquar..., The approval was granted today by the Massachu...ty and quality review of the facility. ,, The ...
(Date:12/3/2009)..., , BEIJING, Dec. 3 /PRNewswire-Asia/...enefits, ginger, one of the most important ingredi...in China during this flu season. , The ti... supply shortages,effecting upward price pressure...potential repeat of the current demand hysteria ov...
(Date:12/3/2009)..., , SILVER SPRING, Md., Dec. 3 /PRNewsw...g a health care system that ensures affordable, qu...on urges all Americans to contact their representa...h care reform. ,, See video from ANA at: http:...dvocating for a health care system that focuses on...
(Date:12/3/2009)...Roles of aggressor, victim often play out at schoo...c. 3 (HealthDay News) -- School bullies are also l... according to an Italian study that included 195 c...rticipants -- all with a sibling no more than four...ether they bullied or were bullied at school or at...
(Date:12/3/2009)...Finding could aid in eventual development of scree...DAY, Dec. 3 (HealthDay News) -- New research point...amin D and heart disease. , People with high bl...itamin D activation in the body were found to be t...e congestive heart failure, the study found. , ...
Breaking Medicine News(10 mins):Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2Health News:VIDEO from Medialink and the American Nurses Association (ANA): American Nurses Association Urges All Americans to Take Part in Health Care Reform Debate 2Health News:Bullies May Intimidate Siblings, Too 2Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2
...anizations are turning to Amalga to connect hospit...h centers., REDMOND, Wash., June 24 To improve t...to medically underserved,D.C. residents, the Distr... hospitals and six community-based health,centers ...
...COUVER, June 24 /PRNewswire-FirstCall/ - Beeston E...BB: BESE) announces that it completed,drilling on ... from,Candorado Operating Company Ltd. (TSX Ventur... copper-gold deposits., The Company is carrying o...
...New evidence-based guidelines address the preventi...ulations and reinforce recommendations related to ... as a supplement in the June issue of CHEST , the...ice Guidelines, Eighth Edition was developed by an...
...cuity,s Release of PriceAdvisor Combats Ineffectiv...action & Improve Revenue Projection and Recovery ...HILLS, Ill. and DUBLIN, Ireland, June 24 /PRNewswi...ology ("Peer,Reviewed by HFMA") and services, toda...
...tery shoppers allow providers to compare real expe...pectations., DALLAS, June 24 Mystery shopping go... why patients leave -- sometimes without,ever meet...come patients because they dismiss a healthcare or...
...3M Health Care today announced the launch of the 3...cal mask to meet the needs of clinicians seeking a...urgical mask incorporates proprietary filtration m... design, the 3M Filtron 1900 surgical mask provide...
Other Medicine News:Health News:District of Columbia Primary Care Association Selects Microsoft Amalga to Improve Patient Care for the Underserved 2Health News:District of Columbia Primary Care Association Selects Microsoft Amalga to Improve Patient Care for the Underserved 3Health News:Beeston completes drilling on Bluff Lake property, 100 Mile House 2Health News:New blood clot guidelines for pregnant women 2Health News:New blood clot guidelines for pregnant women 3Health News:New blood clot guidelines for pregnant women 4Health News:Concuity Announces the Availability of PriceAdvisor 2Health News:Concuity Announces the Availability of PriceAdvisor 3Health News:Concuity Announces the Availability of PriceAdvisor 4Health News:New White Paper from The Beryl Institute: 'Mystery Shopping the Patient Experience' 2Health News:3M Health Care launches new high-performance surgical mask 2
(Date:12/3/2009)... Dec. 3 ParagonRx, a Delaware-base...gement and optimal medication use, will host a fre... guidance on REMS - Risk Evaluation Mitigation Str...ecycle management. Dr. Gary Slatko, chief medical...sk management programs, will lead the one-hour pro...
(Date:12/3/2009)... Cardium Therapeutics (NY...ned subsidiary, Tissue Repair Company, submitted a.... Food and Drug Administration (FDA) seeking marke...didate based on positive data from the Company,s r... Today,s submission with the FDA covers Excellagen...
(Date:12/3/2009)...lif., Dec. 3 Each year, ... United States (U.S.) and Europe participate in th...ry experience under renowned faculty members at th...holars - past, present and future - will have excl...y at www.amgenscholars.com . ,, "The new Web ...
Breaking Medicine Technology:Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 1Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 11Maternal HIV 1 treatment protects against transmission to newborns 59640 1Maternal HIV 1 treatment protects against transmission to newborns 59640 2University of the Basque Country study on proteins related to Alzheimers 10397 1University of the Basque Country study on proteins related to Alzheimers 10397 2
...LES--(BUSINESS WIRE)--Jun 27, 2007 - CytRx Corpora...gaged in the,development and commercialization of ... from the six-month, open-label extension,of its c... in ALS,volunteers. While the clinical trial was n...e three times daily appeared to be safe,and well-t...
...e Netherlands, June 27, 2007-Organon, the human,he...day that two,out of three Phase III clinical trial...g-acting fertility hormone, have reached,their ran...ew recombinant fertility hormone. It is,the first ...cular,stimulant or SFS) of which, due to its long ...
Other Medicine Technology:CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 2CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 3CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 4CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 5Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
Medium Clip Appliers
Li Brand™ Surgical Hemostat
The 2201
No Scalpel Vasectomy Hemostat
Medicine Products: